Introduction to the ninth edition of the Manual of clinical microbiology -- Laboratory management -- Laboratory design -- Laboratory consultation, communication, and information systems -- General ...

Urinary tract infections (UTIs) are common, but increasingly hard to treat because the bacteria that cause them are developing resistance to many antibiotics. Researchers headed by a team at the ...

To date combination therapy for infections by CR GNB is not supported by evidence from a series of adequately sized RCTs. However, pre-clinical data and emerging clinical evidence from observational ...

Gram-positive bacteria show blue or purple after Gram-staining in a laboratory test. They have thick cell walls. Gram-negative bacteria show pink or red on staining and have thin walls. They release ...

Gram-negative bacteria deploy a range of protein toxins as mediators of inter-bacterial competition and pathogenicity. Among these, colicins comprise a class of ribosomally synthesised bacteriocins ...

Aug. 10 (UPI) --A new drug candidate able to fight off more than 300 types of drug-resistant bacteria in the laboratory may be used one day to treat stubborn infections in humans, researchers said ...

In a recent study published in BMC Microbiology, researchers developed the Novel Organism Verification and Analysis (NOVA) algorithm to systematically analyze bacterial isolates unidentified using ...

Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis, while sparing healthy microbes in the mouse ...

Vancomycin is a common antibiotic used to treat gram-positive bacterial infections. It targets a key building block of the bacterial cell wall called Lipid II, but it can’t reach this lipid in ...